Chen Xi, Ma Yu, Jin Qi, Jiang Guang-lu, Li Chuan-you, Wang Qing
Department of Bacteriology and Immunology, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing 101149, China.
Zhonghua Jie He He Hu Xi Za Zhi. 2005 Apr;28(4):250-3.
To study the characteristics of katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
A total of 101 isoniazid-resistant and 43 susceptible strains of Mycobacterium tuberculosis were analyzed by PCR and sequence analysis of their katG, inhA, ahpC, kasA, and oxyR genes.
(1) Sequencing of katG from 101 INH-resistant strains showed point mutations, small deletions or insertions in 81 isolates (80.2%), but no complete deletions were identified. The mutations at 16 position were found for the first time. Point mutations at position 315 were found in the genomes of 38.6% (39/101) of isoniazid-resistant strains. Low level isoniazid resistant strains (1 microg/ml) had higher mutation frequency at 315-Ser than high level isoniazid resistant strains (10 microg/ml; chi(2) = 9.31, P < 0.05). Mutations at position 463 were detected in 58 (57.4%) isoniazid-resistant strains. Arg463leu was also present in 23 of 43 susceptible strains. (2) Mutations in inhA genes were identified in 5 isoniazid-resistant isolates (4.9%). None of the susceptible strains contained any mutation in inhA genes. (3) Only 3 isolates in the 101 (2.97%) isoniazid-resistant clinical isolates had mutations in ahpC genes. No mutations were identified in the ahpC genes in 43 isoniazid-susceptible isolates. (4) Mutations in kasA genes were present in 17 of 101 (16.8%) isoniazid-resistant isolates. However, G312S was also present in 3 of 43 susceptible strains. (5) None of the isoniazid-resistant strains and susceptible isolates contained oxyR gene mutation. (6) Taken together, 91 of 101 (90%) isoniazid-resistant strains had mutations in katG, inhA, ahpC, and kasA genes which were associated with drug resistance.
These studies provide further evidence supporting the association between katG, inhA, ahpC, and kasA gene mutations and INH resistance in Mycobacterium tuberculosis, while other mechanisms of INH resistant may exist.
研究结核分枝杆菌异烟肼耐药临床分离株中katG、inhA、ahpC、kasA和oxyR基因突变特征。
采用聚合酶链反应(PCR)及katG、inhA、ahpC、kasA和oxyR基因序列分析方法,对101株异烟肼耐药结核分枝杆菌和43株敏感菌株进行分析。
(1)101株异烟肼耐药菌株katG基因测序显示,81株(80.2%)存在点突变、小的缺失或插入,但未发现完全缺失。16位的突变系首次发现。38.6%(39/101)的异烟肼耐药菌株基因组中存在315位的点突变。低水平异烟肼耐药菌株(1μg/ml)中315 - 丝氨酸位点的突变频率高于高水平异烟肼耐药菌株(10μg/ml;χ² = 9.31,P < 0.05)。58株(57.4%)异烟肼耐药菌株检测到463位的突变。43株敏感菌株中有23株也存在Arg463leu。(2)5株(4.9%)异烟肼耐药菌株检测到inhA基因突变。敏感菌株inhA基因均未发生突变。(3)101株异烟肼耐药临床分离株中仅3株(2.97%)ahpC基因发生突变。43株异烟肼敏感菌株ahpC基因均未发现突变。(4)101株异烟肼耐药菌株中有17株(16.8%)kasA基因发生突变。然而,43株敏感菌株中有3株也存在G312S。(5)异烟肼耐药菌株和敏感菌株均未检测到oxyR基因突变。(6)总体而言,101株异烟肼耐药菌株中有91株(90%)katG、inhA、ahpC和kasA基因发生突变,这些突变与耐药相关。
本研究进一步证明katG、inhA、ahpC和kasA基因突变与结核分枝杆菌异烟肼耐药相关,同时可能存在其他异烟肼耐药机制。